Thursday, November 5, 2009

Spinal Modulation Gets $27.4M

Menlo Park-based Spinal Modulation, a developer of medical devices for treating back pain, said Thursday that it has raised $27.4M in a Series C funding round. The round came from Johnson & Johnson Development Corporation, DeNovo Ventures, ePlanet/DFJ, Kleiner Perkins Caufield & Byers, MedVenture Associates, DFJ/InCube Ventures and Raffles Venture Partners. The firm said the funding will go toward further development of its products. More information »